Astellas Pharma US, Inc.
18 drugs in NADAC|0 Generic,18 Brand
Astellas Pharma US, Inc. lists 18 NDCs in the CMS NADAC file (0 generic, 18 brand), at an average NADAC of $17.51 per unit, with a week-over-week move of +0.1% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
18
0G / 18B
Avg Price / Unit
$17.5112
$1.64 – $114.00
Avg 7d Change
+0.06%
Across 6 drugs with changes
7d Activity
of 18 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Tacrolimus market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Calcineurin Inhibitor Immunosuppressant therapeutic class
Review the broader class where Astellas Pharma US, Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Astellas Pharma US, Inc. make?
Astellas Pharma US, Inc. lists 18 NDCs in the CMS NADAC file — 0 generic and 18 brand products.
What is the average price of Astellas Pharma US, Inc. drugs?
The average NADAC across Astellas Pharma US, Inc.'s portfolio is $17.5112 per unit, ranging from $1.6383 to $113.9982.
What types of drugs does Astellas Pharma US, Inc. make?
Astellas Pharma US, Inc. makes drugs across 5 FDA pharmacologic classes. The most common by NDC count are Calcineurin Inhibitor Immunosuppressant (8), beta3-Adrenergic Agonist (5), Cholinergic Muscarinic Antagonist (3), Azole Antifungal (1), Neurokinin 3 Receptor Antagonist (1).
Has Astellas Pharma US, Inc. had any drug recalls?
No FDA enforcement recalls are matched to Astellas Pharma US, Inc. in the openFDA feed.
How has Astellas Pharma US, Inc.'s pricing changed recently?
Over the past 7 days, 4 Astellas Pharma US, Inc. products rose and 2 fell, with a portfolio-wide average change of +0.1%.